BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34565306)

  • 1. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
    Li Y; Wei Y; Gu L
    Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
    Gu L; Zhang G; Zhang Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
    Beesley AH; Firth MJ; Ford J; Weller RE; Freitas JR; Perera KU; Kees UR
    Br J Cancer; 2009 Jun; 100(12):1926-36. PubMed ID: 19436302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis.
    Gu L; Zhou C; Liu H; Gao J; Li Q; Mu D; Ma Z
    J Exp Clin Cancer Res; 2010 Nov; 29(1):150. PubMed ID: 21083937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
    Samuels AL; Heng JY; Beesley AH; Kees UR
    Br J Haematol; 2014 Apr; 165(1):57-66. PubMed ID: 24456076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
    Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
    Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
    Tüfekçi Ö; Yandım MK; Ören H; İrken G; Baran Y
    Leuk Res; 2015 Mar; 39(3):342-7. PubMed ID: 25557384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
    Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
    Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells.
    Sudsaward S; Khunchai S; Thepmalee C; Othman A; Limjindaporn T; Yenchitsomanus PT; Mutti L; Krstic-Demonacos M; Demonacos C
    Int J Oncol; 2020 Sep; 57(3):835-844. PubMed ID: 32705154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
    Meyer LK; Delgado-Martin C; Sharp PP; Huang BJ; McMinn D; Vincent TL; Ryan T; Horton TM; Wood BL; Teachey DT; Taunton J; Kirk CJ; Hermiston ML
    Br J Haematol; 2022 Jul; 198(1):137-141. PubMed ID: 35434798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
    Roderick JE; Gallagher KM; Murphy LC; O'Connor KW; Tang K; Zhang B; Brehm MA; Greiner DL; Yu J; Zhu LJ; Green MR; Kelliher MA
    Blood; 2021 Jan; 137(4):500-512. PubMed ID: 33507291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A facile, branched DNA assay to quantitatively measure glucocorticoid receptor auto-regulation in T-cell acute lymphoblastic leukemia.
    Schwartz JR; Sarvaiya PJ; Leiva LE; Velez MC; Singleton TC; Yu LC; Vedeckis WV
    Chin J Cancer; 2012 Aug; 31(8):381-91. PubMed ID: 22739263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
    Gu L; Xie L; Zuo C; Ma Z; Zhang Y; Zhu Y; Gao J
    BMC Cancer; 2015 Jul; 15():529. PubMed ID: 26189041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.
    Zou J; Li P; Lu F; Liu N; Dai J; Ye J; Qu X; Sun X; Ma D; Park J; Ji C
    J Hematol Oncol; 2013 Jan; 6():3. PubMed ID: 23289374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of glucocorticoid receptor isoforms expression in acute lymphoblastic leukemia correlate with glucocorticoid resistance.
    Sun X; Fang M; Guan Y; Si Y; Ma L; Wang Y; Jia Z
    Pharmazie; 2015 May; 70(5):316-21. PubMed ID: 26062300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells.
    Kullmann MK; Grubbauer C; Goetsch K; Jäkel H; Podmirseg SR; Trockenbacher A; Ploner C; Cato AC; Weiss C; Kofler R; Hengst L
    Cell Cycle; 2013 Aug; 12(16):2625-35. PubMed ID: 23907123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia.
    Shi Y; Beckett MC; Blair HJ; Tirtakusuma R; Nakjang S; Enshaei A; Halsey C; Vormoor J; Heidenreich O; Krippner-Heidenreich A; van Delft FW
    Haematologica; 2021 Apr; 106(4):1056-1066. PubMed ID: 32139432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.